Partnership Landscape - Q2 2026
.png)
Updated as of April 1, 2026
Notes:
1. Company size corresponds with number of partnerships, link thickness corresponds with recency of the partnership (thicker lines are more recent; partnerships for which a year could not be established are set at minimum thickness).
2. Partnership activity was pulled from company websites and press releases and is based on publicly available information. Research collaborations that have resulted in pubs / conference abstracts but that have not been publicized as partnerships may not be included. Only includes partnerships announced 2020-2025
3. Many companies have offerings spanning multiple product categories; the primary or most comprehensive product offering was used for node shading.
4. Incubators, accelerators, research groups, and investors were excluded.
5. There are additional pathology companies that have been excluded because they do not have digital pathology offerings. Partnerships with companies that are unrelated to digital pathology have been excluded
Comments and opinions expressed by interviewees are their own and do not represent or reflect the opinions, policies, or positions of DeciBio Consulting or have its endorsement. Note: DeciBio Consulting, its employees or owners, or our guests may hold assets discussed in this article/episode. This article/blog/episode does not provide investment advice, and is intended for informational and entertainment purposes only. You should do your own research and make your own independent decisions when considering any financial transactions.
.png)
